| Serial Number | 85362627 |
| Word Mark | RHUDEX |
| Filing Date | Monday, July 4, 2011 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, November 29, 2019 |
| Registration Number | 4322812 |
| Registration Date | Tuesday, April 23, 2013 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 17, 2012 |
| Goods and Services | Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, and CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics; pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases |
| Goods and Services | Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors and syringes |
| Goods and Services | Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property, namely, trademarks and patents in the field of biotechnology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 29, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 29, 2019 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 29, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Medigene Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Oxfordshire OX144RX GB |
| Party Name | Medigene Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Oxfordshire OX144RX GB |
| Party Name | Medigene Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Oxfordshire OX144RX GB |
| Event Date | Event Description |
| Friday, November 29, 2019 | CANCELLED SEC. 8 (6-YR) |
| Monday, April 23, 2018 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, April 23, 2013 | REGISTERED-PRINCIPAL REGISTER |
| Monday, March 18, 2013 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, March 5, 2013 | NOTICE OF ALLOWANCE CANCELLED |
| Monday, March 11, 2013 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, March 5, 2013 | TEAS DELETE 1(B) BASIS RECEIVED |
| Tuesday, September 11, 2012 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 17, 2012 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 17, 2012 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 27, 2012 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, June 14, 2012 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, June 13, 2012 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 17, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 17, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 4, 2012 | ASSIGNED TO LIE |
| Thursday, May 3, 2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 3, 2011 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 3, 2011 | NON-FINAL ACTION E-MAILED |
| Thursday, November 3, 2011 | NON-FINAL ACTION WRITTEN |
| Thursday, October 20, 2011 | ASSIGNED TO EXAMINER |
| Monday, July 11, 2011 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, July 7, 2011 | NEW APPLICATION ENTERED IN TRAM |